[Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]. FE [Internet]. 2016 Dec. 21 [cited 2025 Oct. 29];17(3S):1-32. Available from: https://journals.seedstm.com/index.php/FE/article/view/1279